Related references
Note: Only part of the references are listed.In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans
Elina Erikson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antibody-Based Therapies in Multiple Myeloma
Yu-Tzu Tai et al.
BONE MARROW RESEARCH (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery
Rikke Leth-Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms
Erik Wallin et al.
PROTEIN SCIENCE (2010)
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody
Wei Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Applications of Proteomics in the Study of Inflammatory Bowel Diseases: Current Status and Future Directions with Available Technologies
Philip Alex et al.
INFLAMMATORY BOWEL DISEASES (2009)
Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin
Nolwenn Jouvenet et al.
JOURNAL OF VIROLOGY (2009)
Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells
Wei Wang et al.
LUNG CANCER (2009)
Interferon-α enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models
Shigeto Kawai et al.
CANCER SCIENCE (2008)
Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation
Erin M. Conn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells
Haibo Qiu et al.
JOURNAL OF PROTEOME RESEARCH (2008)
The ties that bind a virus to the cell
Robert P. Kruger
CELL (2008)
Membrane proteins and membrane proteomics
Sandra Tan et al.
PROTEOMICS (2008)
Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells
Philippe Kischel et al.
NEOPLASIA (2008)
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Stuart J. D. Neil et al.
NATURE (2008)
8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease
Leila Choe et al.
PROTEOMICS (2007)
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling
Y. F. Wong et al.
ONCOGENE (2007)
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration
C. E. Humber et al.
ANNALS OF ONCOLOGY (2007)
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
Kathy Mulgrew et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Creation of tumorigenic human endometrial epithelial cells with intact chromosomes by introducing defined genetic elements
Y. Mizumoto et al.
ONCOGENE (2006)
Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity
Tom van Meerten et al.
CLINICAL CANCER RESEARCH (2006)
Comparing antibody and small-molecule therapies for cancer
Kohzoh Imai et al.
NATURE REVIEWS CANCER (2006)
Comparison of normal and breast cancer cell lines using proteome, genome, and interactome data
AJ Patwardhan et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping
SB Scheurer et al.
PROTEOMICS (2005)
Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma
K Mimura et al.
CLINICAL CANCER RESEARCH (2005)
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma
R Marcus et al.
BLOOD (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Proteomic analysis of integral plasma membrane proteins
YX Zhao et al.
ANALYTICAL CHEMISTRY (2004)
Identification and validation of cell surface antigens for antibody targeting in oncology
P Carter et al.
ENDOCRINE-RELATED CANCER (2004)
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group study
GF Fleming et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Integrated genomic and proteomic analyses of gene expression in mammalian cells
Q Tian et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas
M Fogel et al.
LANCET (2003)
Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways
A Matsuda et al.
ONCOGENE (2003)
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function
BK Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Successful immortalization of endometrial glandular cells with normal structural and functional characteristics
S Kyo et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Discordant protein and mRNA expression in lung adenocarcinomas
GA Chen et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation
GL Mutter et al.
GYNECOLOGIC ONCOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
